Snapshot
The Inscription of Orphan Drugs pathway has been developed by the of Panama.
This pathway accelerates the regulatory review process.
It is an abridged review (a reliance pathway).
Target time assessment is .
The Inscription of Orphan Drugs pathway has been developed by the of Panama.
This pathway accelerates the regulatory review process.
It is an abridged review (a reliance pathway).
Target time assessment is .